The basic principles of immunosuppressive therapy after kidney transplantation
The article deals with medical and organizational issues of individually-adapted immunosuppressive therapy in renal allograft recipients. In the recent years, the basis of nephroprotective therapy schemes includes m-TOR inhibitors. The accessibility of these drugs for those in need is limited. Meanw...
Saved in:
| Main Author: | D. N. Suslov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-03-01
|
| Series: | Трансплантология (Москва) |
| Subjects: | |
| Online Access: | https://www.jtransplantologiya.ru/jour/article/view/215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of immunosuppressive therapy on pulmonary perfusion in kidney transplant recipients after COVID-19 illness
by: Barbara Infante, et al.
Published: (2025-06-01) -
Adverse effects of immunosuppressive therapy after kidney transplant
by: S. V. Popov, et al.
Published: (2025-03-01) -
Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01) -
Immunosuppressive therapy and nutritional diseases of patients after kidney transplantation: a systematic review
by: Aleksandra Anna Kajdas, et al.
Published: (2025-01-01) -
Immunosenescence as a reason of individualizing immunosuppressive therapy in kidney transplantation
by: V. A. Fedulkina, et al.
Published: (2021-09-01)